succinate
-
Watson Receives Approval for Heart Failure Drug
Watson Laboratories has received approval from the US Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for metoprolol succinate extended-release tablets USP in the 100 and 200 mg strengths, the generic equivalent to A…
succinate | 22 April 2010
-
Sun Pharma Announces Approval for Generic Drugs
Sun Pharmaceutical Industries has announced that the US Food and Drug Administration (FDA) has granted approvals for two Abbreviated New Drug Applications (ANDAs) – the generic version of Eloxatin, oxaliplatin for injection and the generic ver…
succinate | 01 September 2009
